Présentation de l'entreprise

“NON-OPIATE APPROACH FOR THE MANAGEMENT OF PAIN
Pharmaleads designs and develops innovative, non-opiate medicines for the management of acute and chronic severe pain, a growing market with significant unmet medical needs.

Our drugs under development, Dual ENKephalinase inhibitors (DENKIs), are based on our deep knowledge and understanding of enkephalins which are a key element of the physiological pain modulation system. DENKIs work by protecting enkephalins from their degrading enzymes thereby increasing their local concentrations and, as a result, inducing a greater physiological analgesia to locally improve pain management” From http://www.pharmaleads.com/